Cristina Viaplana

A <scp>RAD</scp> 51 assay feasible in routine tumor samples calls <scp>PARP</scp> inhibitor response beyond <scp>BRCA</scp> mutation

Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara et al. · EMBO Molecular Medicine · 2018 · 263 citations · Full text

OncoTree: A Cancer Classification System for Precision Oncology

Ritika Kundra, Hongxin Zhang, Robert P. Sheridan et al. · JCO Clinical Cancer Informatics · 2021 · 136 citations · Full text

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet et al. · Nature Communications · 2022 · 113 citations · Full text

A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Marta Ligero, Alonso García-Ruiz, Cristina Viaplana et al. · Radiology · 2021 · 102 citations

Preclinical <i>In Vivo</i> Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop‐Guevara et al. · Cancer Research · 2022 · 86 citations · Full text